본문 바로가기
  • Home

Necessity and condition of terms for ‘Human Embryo and Germ-line genetic modification’

  • Journal of the Korea Bioethics Association
  • 2020, 21(1), pp.57-70
  • DOI : 10.37305/JKBA.2020.06.21.1.57
  • Publisher : The Korean Bioethics Association
  • Research Area : Interdisciplinary Studies > Interdisciplinary Research
  • Received : April 22, 2020
  • Accepted : June 23, 2020
  • Published : June 30, 2020

Moon Hannah 1

1(재) 국가생명윤리정책원

Accredited

ABSTRACT

In terms of modifying DNA information in human cells, various terms are used depending on the purpose, object, method, and result, and the definitions of the terms are different. For example, gene therapy, genetic variation, genetic modification, genome editing. In particular, the terms used in the areas of domestic and foreign laws need to be examined in detail because they reveal differences in regulatory power. It is important to develop a consensus term that have appropriate implications at the present time, as technologies are being developed that can modify genetic information and discussions of research permits for embryos and germ cell subjects are active. Therefore, this paper should summarize the definition of gene therapy that has been used in the law, examine whether it can be used in embryos and germ cells, while referring to overseas cases, I would like to suggest a term suitable for use in Korea. Beginning with this discussion, it is hoped that further discussions on relevant legislative improvements, such as relevant review procedures and regulatory methods, with regard to genetic modifications will be made on the basis of agreed terms in society.

Citation status

* References for papers published after 2023 are currently being built.